Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CASR | P41180 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MTOR | P42345 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7189369 | 1.00 | ACP3 (0.53) | ACP3SMN1; SMN2SIGMAR1MEN1KMT2A | |
| SCHEMBL14099897 | 1.00 | ACP3 (0.53) | ACP3SMN1; SMN2SIGMAR1MEN1KMT2A | |
| SCHEMBL2189859 | 0.87 | SIGMAR1 (0.55) | ACP3SMN1; SMN2SIGMAR1MEN1KMT2A | |
| SCHEMBL13191170 | 0.86 | AOC3 (0.55) | ACP3SMN1; SMN2SIGMAR1MEN1KMT2A | |
| SCHEMBL17775606 | 0.86 | DPP4 (0.48) | ACP3SMN1; SMN2SIGMAR1MEN1KMT2A | |
| SCHEMBL17465582 | 0.86 | PLA2G1B (0.49) | ACP3SMN1; SMN2SIGMAR1MEN1KMT2A | |
| SCHEMBL5269591 | 0.86 | AOC3 (0.55) | ACP3SMN1; SMN2SIGMAR1MEN1KMT2A | |
| SCHEMBL17314012 | 0.84 | SIGMAR1 (0.52) | ACP3SMN1; SMN2SIGMAR1MEN1KMT2A | |
| SCHEMBL7385115 | 0.82 | ACP3 (0.51) | ACP3SMN1; SMN2SIGMAR1MEN1KMT2A | |
| SCHEMBL2190756 | 0.82 | SIGMAR1 (0.50) | ACP3SMN1; SMN2SIGMAR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2114899-B1 | CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES | FIRMENICH & CIE (CH) | 2010-09-22 | — | — | EP | claimed |
| US-20100098650-A1 | CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES | FIRMENICH SA (CH) | 2010-04-22 | — | — | US | claimed |
| EP-2114899-A2 | CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES | Firmenich S.A. (CH) | 2009-11-11 | — | — | EP | claimed |
| WO-2008093272-A2 | CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES | FIRMENICH SA (CH) | 2008-08-07 | — | — | WO | claimed |
| EP-1970360-B1 | Method for producing alcohols | TAKASAGO PERFUMERY CO LTD (JP) | 2016-08-31 | — | — | EP | disclosed |
| EP-2392400-B1 | Homogeneous asymmetric hydrogenation method | TAKASAGO PERFUMERY CO LTD (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-8586498-B2 | Homogeneous asymmetric hydrogenation catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-11-19 | — | — | US | disclosed |
| US-8497400-B2 | Homogeneous asymmetric hydrogenation process | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-07-30 | — | — | US | disclosed |
| US-8481791-B2 | Homogeneous asymmetric hydrogenation process | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-07-09 | — | — | US | disclosed |
| EP-2392400-A2 | Homogeneous asymmetric hydrogenation catalyst | Takasago International Corporation (JP) | 2011-12-07 | — | — | EP | disclosed |
| US-8053592-B2 | Method for producing optically active α-ionone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-11-08 | — | — | US | disclosed |
| US-20110118500-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE a-IONONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| EP-2095875-A1 | Homogeneous asymmetric hydrogenation catalyst | Takasago International Corporation (JP) | 2009-09-02 | — | — | EP | disclosed |
| US-20090216039-A1 | Method for Producing Optically Active Alpha-Ionone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090203927-A1 | Homogeneous asymmetric hydrogenation catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-7569735-B2 | Reducing esters or lactones with hydrogen gas in presence of ruthenium catalyst; high yield and high catalytic efficiency under an industrially advantageous condition of relatively low hydrogen pressure and low reaction temperature | TAKASAGO INTERNATIONAL (JP) | 2009-08-04 | — | — | US | disclosed |
| US-20080228012-A1 | Reducing esters or lactones with hydrogen gas in presence of ruthenium catalyst; high yield and high catalytic efficiency under an industrially advantageous condition of relatively low hydrogen pressure and low reaction temperature | TAKASAGO INTERNATIONAL CORPORATION | 2008-09-18 | — | — | US | disclosed |
| EP-1970360-A1 | Method for producing alcohols | Takasago International Corporation (JP) | 2008-09-17 | — | — | EP | disclosed |
| WO-2008093272-A2 | CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES | FIRMENICH SA (CH) | 2008-08-07 | — | — | WO | disclosed |
| EP-1911516-A1 | HOMOGENEOUS ASYMMETRIC HYDROGENATION CATALYST | Takasago International Corporation (JP) | 2008-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118500-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE a-IONONE | INF2, HSD17B1, AGL | ACP3 2080/4885SMN1; SMN2 3824/4885SIGMAR1 1984/4885 |
| US-20090203927-A1 | Homogeneous asymmetric hydrogenation catalyst | HDHD5, HHAT, HACL2 | ACP3 3342/4885SMN1; SMN2 2876/4885SIGMAR1 1852/4885 |
| US-20080228012-A1 | Reducing esters or lactones with hydrogen gas in presence of ruthenium catalyst; high yield and high catalytic efficiency under an industrially advantageous condition of relatively low hydrogen pressure and low reaction temperature | LPXN, LIPE, MLX | ACP3 745/4885SMN1; SMN2 4214/4885SIGMAR1 1460/4885 |
| US-20090216039-A1 | Method for Producing Optically Active Alpha-Ionone | HSD17B1, ENO1, INF2 | ACP3 2413/4885SMN1; SMN2 3731/4885SIGMAR1 1528/4885 |
| US-20100098650-A1 | CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES | PKM, APEH, PLG | ACP3 4022/4885SMN1; SMN2 2922/4885SIGMAR1 576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.